Catalyst check off: X 1. Cash Flow Positive Status - 5 years X 2. Purchase building housing their cGMP registered facility for research, development, manufacturing and packaging of pharmaceutical products. X 3. Adderall IR $335 Million Approved and Launched X 4. Adderall XR $1.56 Billion Approved and Launched X 5. Double digit quarterly revenues in millions X 6. In house marketing and distribution: Kirko Kirkov, Doug Plassche and their teams X 7. Prasco/Burel Adderall agreement starting January 1st 2024 X 8. First shipment Adderall XR to PRASCO Dec 2023 X 9. DEA increases manufacturing quotas for Adderall & Vyvance X 10. Generic Vyvanse - $5.1 BILLION - FDA submission Dec 2023 X 11. FDA Acceptance of Generic OxyContin Sept 2023 __12. Dopamine Agonist (probably Requip XL or Mirapex ER). $12 Million X 13. Vigabatrin Approval $233 Million __14. Pyros Settle Vigabatrin -VigPoder trade mark challenge then Launch __15. Generic Methotrexate Approval- Antimetabolite $42 Million __16. $50 million in yearly revenues X 17. Lease additional manufacturing space and storage vault for new Needle Mover ANDAs - Jan 2024 __18. Generate revenues over $20 million/quarter __19. Generic OxyContin Approval - FIRST TO FILE Aug 17, 2023 $720 Million __20. Prevail over Purdue in Generic OxyContin infringement suit - 6 month stay __21. European distribution - Dexcel partnership approval by Israeli Health __22. Full ownership of Adderall IR $ 335 Million __23. Full ownership of Adderall XR $ 1.56 Billion __24. Generic Concerta- $1.2 BILLION FDA submission __25. $100 million in yearly revenue __26. Generic Vyvanse Approval and Launch __27. $200 million in yearly revenue __28. Deep pocket partner for SequestOx __29. Patented Unique ADF (w/o naltrexone)-- NDA __30. Mikah ANDA (s) __31. Undisclosed ANDAs/NDAs __32. DollarLand PPS __33. Uplist to the NASDAQ Exchange __34. ELTP Elite Pharmaceutical Buyout - less than 2 1/2 years from Feb 2024 __35. Vegas Baby !!!!!!! X 36. PE below 8
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.